Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

CADLCADL
19 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in CANDEL THERAPEUTICS INC

NORTHERN TRUST CORP holds 492,465 shares of CADL (CANDEL THERAPEUTICS INC), worth $5.1M as of 2026-Q2. The position was increased (+52.4% shares). CADL represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$5.1M

Current Shares

492,465

Total Value Change

+$5M

Total Shares Change

+479,010

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
492,465
+52.4%
$5.1M0.0%$10.30
38
2026-Q1
Increased
323,154
+9.4%
$1.6M0.0%$4.91
28
2025-Q4
Decreased
295,438
-3.7%
$1.7M0.0%$5.71
0
2025-Q3
Increased
306,775
+6.6%
$1.6M0.0%$5.40
27
2025-Q2
Increased
287,863
+22.2%
$1.5M0.0%$4.90
31
2025-Q1
Increased
235,536
+42.7%
$1.3M0.0%$5.95
34
2024-Q4
Increased
165,021
+3.9%
$1.4M0.0%$7.95
27
2024-Q3
Increased
158,771
+265.4%
$1.1M0.0%$7.21
41
2024-Q2
Increased
43,445
+122.7%
$269,3590.0%$6.20
26
2024-Q1
Decreased
19,507
-0.6%
$30,8210.0%$1.58
0
2023-Q4
Unchanged
19,617
0.0%
$28,8370.0%$1.47
0
2023-Q3
Unchanged
19,617
0.0%
$18,0480.0%$0.92
0
2023-Q2
Unchanged
19,617
0.0%
$24,7170.0%$1.24
0
2023-Q1
Increased
19,617
+35.5%
$26,4830.0%$1.38
17
2022-Q4
Unchanged
14,483
0.0%
$25,9250.0%$1.79
0
2022-Q3
Unchanged
14,483
0.0%
$45,0000.0%$3.20
0
2022-Q2
Increased
14,483
+7.6%
$47,0000.0%$3.39
15
2022-Q1
Unchanged
13,455
0.0%
$68,0000.0%$4.59
0
2021-Q4
New
13,455
-
$105,0000.0%$7.97
33

Other major holders of CADL: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used